Health
Inhaled steroids reduce SARS-CoV-2-related genes in COPD – News-Medical.Net
A new study published on the preprint server medRxiv* aims to explore the effects of treatment with ICS on the expression of specific genes related to SARS-CoV-2 infection in bronchial epithelial cells in a prospective interventional design.
The chronic lung condition called COPD (chronic obstructive pulmonary disease) increases the risk of severe COVID-19.
Inhaled corticosteroids (ICS) are commonly prescribed to stabilize respiratory function in these patients, but the associated risk of bacterial infection has daunted some healthcare professionals from using them. Moreover, in vitro, studies show that they have an immunosuppressive effect on cells exposed to viruses. There is no evidence to reveal the effects of ICS on either sus…
-
General22 hours agoCarrie Bickmore named Victorian Australian of the Year for work to progress brain cancer research
-
General23 hours agoNT Police Force announces anti-racism action plan in bid to drive cultural change
-
Noosa News23 hours agoMum takes solace son died knowing he was deeply loved
-
Noosa News20 hours agoAustralia’s $4 billion illicit tobacco trade has become one of the nation’s most violent criminal markets
